NCT05208944 2026-01-20THIO Sequenced With Cemiplimab in Advanced NSCLCMaia BiotechnologyPhase 2 Recruiting227 enrolled
NCT06908304 2026-01-12A Phase III Study With THIO + Cemiplimab vs Chemotherapy as 3rd Line Treatment in Advanced/Metastatic NSCLCMaia BiotechnologyPhase 3 Recruiting300 enrolled